Quantum-Si: Sell On Weak Prospects And Risk Of Further Dilution

  • After mistakenly having been picked up as a quantum computing play in late 2024, shares of life sciences company, Quantum-Si, have given back most of their gains in recent months. While the company used the hype to replenish its dwindling cash balances, dilution for common shareholders has been substantial. Quantum-Si remains years behind its original business plan with an inflection point nowhere in sight. The company continues to burn substantial amounts of cash.